Skip to main content

Table 2 The results of WB, IF, Transwell and Would healing assay (\( \overline{\mathrm{x}} \) ± SD)

From: RETRACTED ARTICLE: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer

 

Control group

nab-P group

AP group

WB (relative gray value)

Bax

0.04 ± 0.01

0.13 ± 0.07

0.14 ± 0.09

bcl-2

0.26 ± 0.01

0.09 ± 0.01

0.09 ± 0.01

p-VEGFR-2

0.14 ± 0.04

0.14 ± 0.06

0.04 ± 0.01

MMP-2

0.14 ± 0.01

0.04 ± 0.01

0.05 ± 0.01

IF (positive rate%)

Bax

2.01% ± 0.39

13.87% ± 1.91**

14.17% ± 1.69**

bcl-2

23.9% ± 1.04

13.87% ± 2.45**

15.67% ± 1.31**

p-VEGFR-2

25.17% ± 0.97

25.8% ± 1.94

7.4% ± 0.88**

MMP-2

19.3% ± 1.16

10.4% ± 0.85**

10.83% ± 1.92**

Transwell (invasion cellular amount)

389 ± 25.8

41 ± 7.6**

53 ± 4.7**

Wound healing (Area recovery%)

12 h

63.54% ± 3.64

−3.89% ± 0.51**

−9.85% ± 0.62**

24 h

84.88% ± 1.75

1.76% ± 0.12**

−5.87% ± 0.62**

  1. Note: ** P < 0.01, medication group vs control group